Storia in 7 fonti

Millions more Americans could access obesity drugs after Trump's deals with Eli Lilly, Novo Nordisk

Medicare will start covering obesity drugs for the first time, which could open access to millions of seniors and spur more private insurers to follow suit.

Raccontata da

giovedì 6 novembre 2025·forbes.com
Trump Says Obesity Drugmakers Will Cut GLP-1 Prices—Medicare Will Cover Some Costs
The deal also means Medicare will start covering obesity drugs for some patients for the first time beginning next year.
giovedì 6 novembre 2025·ilsole24ore.com
Trump, accordo per farmaci antiobesità alla portata di tutti
Il presidente, Eli Lilly e Novo Nordisk hanno presentato un accordo per ridurre i prezzi dei popolari farmaci dimagranti Zepbound e Wegovy a base di GLP-1 per i programmi…

Millions more Americans could access obesity drugs after Trump's deals with Eli Lilly, Novo Nordisk

Trump Says Obesity Drugmakers Will Cut GLP-1 Prices—Medicare Will Cover Some Costs

Trump, accordo per farmaci antiobesità alla portata di tutti

Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer some Medicare coverage

Trump unveils deals to lower US weight-loss drug prices

Trump punches new $35 billion hole in national debt with deal for Medicare to cover your Ozempic | Fortune

Here's how much weight loss drugs could cost you under Trump's deals with Eli Lilly, Novo Nordisk

Trump announces deal to lower prices for obesity drugs - UPI.com

Weight-loss drug makers announce pricing agreement with Trump

Millions more Americans could access obesity drugs after Trump's deals with Eli Lilly, Novo Nordisk